Bright, photostable, and long-circulating NIR-II nanoparticles for wholeprocess monitoring and evaluation of renal transplantation

02 March 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


Kidney transplantation is the gold standard for the treatment of end-stage renal disease (ESRD). However, the scarcity of kidneys has caused more and more ESRD patients being stuck on the waiting-list for surgery. Improving the survival rate of kidney grafts as much as possible is not only responsible for patients, but also an alternative solution to kidney shortage. Thus, rapid diagnosis and timely management of surgical complications are of vital importance to the success of renal transplantation but lack efficient methods and technologies. Herein, a fluorescence technology based on bright, photostable, and long-circulating aggregation-induced emission (AIE) active NIR-II nano contrast agent for the whole-process monitoring and evaluation of renal transplantation has been reported. The outstanding optical property and long-circulating characteristic of the AIE NPs help to achieve renal angiography in the kidney retrieval surgery, donor kidney quality evaluation before transplantation, diagnosing vascular complications, and assessment of renal graft reperfusion after revascularization, which considerably outperforms the clinically approved indocyanine green (ICG).


aggregation-induced emission (AIE)
Kidney transplantation
NIR-II imaging
end-stage renal disease (ESRD)


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.